Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Satoshi Anai

Showing results (71-80 of 175) with videos related to

Pageof 18
Sort By:
Urologic Oncology|April 4, 2016
Neutrophil-to-lymphocyte ratio as a detection marker of tumor recurrence in patients with muscle-invasive bladder cancer after radical cystectomyYosuke Morizawa, Makito Miyake, Keiji Shimada, et al.
Cancer Science|March 8, 2014
Diagnostic approach for cancer cells in urine sediments by 5-aminolevulinic acid-based photodynamic detection in bladder cancerMakito Miyake, Yasushi Nakai, Satoshi Anai, et al.
Bladder (San Francisco, Calif.)|November 14, 2024
Bladder preservation with concurrent chemoradiotherapy for muscle-invasive bladder cancer: Retrospective comparison of three regimensMakito Miyake, Yusuke Iemura, Yuki Oda, et al.
Advances in Urology|June 2, 2012
Calculated tumor volume is an independent predictor of biochemical recurrence in patients who underwent retropubic radical prostatectomyNobumichi Tanaka, Kiyohide Fujimoto, Akihide Hirayama, et al.
BMC Urology|April 7, 2017
Transperineal template-guided saturation biopsy aimed at sampling one core for each milliliter of prostate volume: 103 cases requiring repeat prostate biopsyYasushi Nakai, Nobumichi Tanaka, Satoshi Anai, et al.
BMC Cancer|May 21, 2015
Risk factors of PSA progression and overall survival in patients with localized and locally advanced prostate cancer treated with primary androgen deprivation therapyAtsushi Tomioka, Nobumichi Tanaka, Motokiyo Yoshikawa, et al.
Japanese Journal of Clinical Oncology|August 25, 2011
Bone scan can be spared in asymptomatic prostate cancer patients with PSA of <=20 ng/ml and Gleason score of <=6 at the initial stage of diagnosisNobumichi Tanaka, Kiyohide Fujimoto, Takayuki Shinkai, et al.
BMC Urology|April 30, 2014
Nadir PSA level and time to nadir PSA are prognostic factors in patients with metastatic prostate cancerAtsushi Tomioka, Nobumichi Tanaka, Motokiyo Yoshikawa, et al.
World Journal of Surgical Oncology|February 26, 2016
Extended resection including adjacent organs and Ki-67 labeling index are prognostic factors in patients with retroperitoneal soft tissue sarcomasYosuke Morizawa, Makito Miyake, Keiji Shimada, et al.
Photodiagnosis and Photodynamic Therapy|July 31, 2015
Expression of ferrochelatase has a strong correlation in protoporphyrin IX accumulation with photodynamic detection of bladder cancerYasushi Nakai, Yoshihiro Tatsumi, Makito Miyake, et al.
Pageof 18

Showing results (71-80 of 175) with videos related to

Sort By:
Pageof 18
Urologic Oncology|April 4, 2016
Neutrophil-to-lymphocyte ratio as a detection marker of tumor recurrence in patients with muscle-invasive bladder cancer after radical cystectomyYosuke Morizawa, Makito Miyake, Keiji Shimada, et al.
Cancer Science|March 8, 2014
Diagnostic approach for cancer cells in urine sediments by 5-aminolevulinic acid-based photodynamic detection in bladder cancerMakito Miyake, Yasushi Nakai, Satoshi Anai, et al.
Bladder (San Francisco, Calif.)|November 14, 2024
Bladder preservation with concurrent chemoradiotherapy for muscle-invasive bladder cancer: Retrospective comparison of three regimensMakito Miyake, Yusuke Iemura, Yuki Oda, et al.
Advances in Urology|June 2, 2012
Calculated tumor volume is an independent predictor of biochemical recurrence in patients who underwent retropubic radical prostatectomyNobumichi Tanaka, Kiyohide Fujimoto, Akihide Hirayama, et al.
BMC Urology|April 7, 2017
Transperineal template-guided saturation biopsy aimed at sampling one core for each milliliter of prostate volume: 103 cases requiring repeat prostate biopsyYasushi Nakai, Nobumichi Tanaka, Satoshi Anai, et al.
BMC Cancer|May 21, 2015
Risk factors of PSA progression and overall survival in patients with localized and locally advanced prostate cancer treated with primary androgen deprivation therapyAtsushi Tomioka, Nobumichi Tanaka, Motokiyo Yoshikawa, et al.
Japanese Journal of Clinical Oncology|August 25, 2011
Bone scan can be spared in asymptomatic prostate cancer patients with PSA of <=20 ng/ml and Gleason score of <=6 at the initial stage of diagnosisNobumichi Tanaka, Kiyohide Fujimoto, Takayuki Shinkai, et al.
BMC Urology|April 30, 2014
Nadir PSA level and time to nadir PSA are prognostic factors in patients with metastatic prostate cancerAtsushi Tomioka, Nobumichi Tanaka, Motokiyo Yoshikawa, et al.
World Journal of Surgical Oncology|February 26, 2016
Extended resection including adjacent organs and Ki-67 labeling index are prognostic factors in patients with retroperitoneal soft tissue sarcomasYosuke Morizawa, Makito Miyake, Keiji Shimada, et al.
Photodiagnosis and Photodynamic Therapy|July 31, 2015
Expression of ferrochelatase has a strong correlation in protoporphyrin IX accumulation with photodynamic detection of bladder cancerYasushi Nakai, Yoshihiro Tatsumi, Makito Miyake, et al.
Pageof 18